State Key Lab of New Drug & Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, Shanghai 200437, China.
Bioorg Med Chem Lett. 2011 Nov 15;21(22):6732-8. doi: 10.1016/j.bmcl.2011.09.045. Epub 2011 Sep 18.
Thirty-one N(4)-mono alkyl derivatives of novel glycopeptide LYV07ww01 were synthesized by the reductive alkylation and their in vitro antibacterial activity was tested. The benzyl derivatives showed potent activity, especially against vancomycin-resistant enterococci and penicillin-resistant Streptococcus pneumoniae.
合成了 31 种新型糖肽 LYV07ww01 的 N(4)-单烷基衍生物,并测试了它们的体外抗菌活性。苄基衍生物表现出很强的活性,特别是对万古霉素耐药肠球菌和青霉素耐药肺炎链球菌。